View full meeting coverage »

Eyetube Meeting Coverage:

Retina Updates Spring 2020

 

Editorially Independent Content, Financially Supported by

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Phase 1/2A Data on Transplantation of hESC-Derived RPE Cells for Dry AMD

  Channels: Retina | Posted 5/13/2020

Christopher D. Riemann, MD, shares data from a phase 1/2A study evaluating the safety of transplantation of human embryonic stem cell–derived retinal pigment epithelium cells for the purpose of treating dry AMD. Dr. Riemann educates viewers about the science behind this technique, and outlines interim data from four cohorts of patients.

Clinical Trials • drusen • dry age-related macular degeneration, dry AMD • Retinal Pigment Epithelium (RPE) • stem cell therapy


8 / 10 Series: Retina Updates Spring 2020


These programs are not affiliated with the official program of ARVO 2020.